Evidence map›Paper›PMID 34576100›Full record

ArticleInternational journal of molecular sciences2021

Cellular Integrin α5β1 and Exosomal ADAM17 Mediate the Binding and Uptake of Exosomes Produced by Colorectal Carcinoma Cells.

Beatriz Cardeñes, Irene Clares, Víctor Toribio, Lucía Pascual, Soraya López-Martín, Alvaro Torres-Gomez, Ricardo Sainz de la Cuesta, Esther M Lafuente, Manuel López-Cabrera, María Yáñez-Mó and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Beatriz CardeñesCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Irene ClaresCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Víctor ToribioCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Lucía PascualCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Soraya López-MartínCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.
Alvaro Torres-GomezDepartment of Immunology, Ophthalmology and Otorhinolaryngology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0002-7377-1581
Ricardo Sainz de la CuestaDepartment of Obstetrics and Gynecology, Hospital Universitario Quironsalud Madrid, 28223 Madrid, Spain.
Esther M LafuenteDepartment of Immunology, Ophthalmology and Otorhinolaryngology, School of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.ORCID 0000-0001-8466-1022
Manuel López-CabreraCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.ORCID 0000-0002-0976-9719
María Yáñez-MóCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.ORCID 0000-0001-7484-2866
Carlos CabañasCentre for Molecular Biology "Severo Ochoa" (CSIC-UAM), Cell-Cell Communication & Inflammation Unit, 28049 Madrid, Spain.ORCID 0000-0002-8767-060X
Centro de Biología Molecular Severo Ochoa · ESUniversidad Complutense de Madrid · ESHospital Universitario de La Princesa · ESHospital Universitario Quirónsalud Madrid · ES

Funding

Ministry of Economy, Industry and Competitiveness SAF2016-77096-R
6 · The paper itself

Abstract

Approximately 25% of colorectal cancer (CRC) patients develop peritoneal metastasis, a condition associated with a bleak prognosis. The CRC peritoneal dissemination cascade involves the shedding of cancer cells from the primary tumor, their transport through the peritoneal cavity, their adhesion to the peritoneal mesothelial cells (PMCs) that line all peritoneal organs, and invasion of cancer cells through this mesothelial cell barrier and underlying stroma to establish new metastatic foci. Exosomes produced by cancer cells have been shown to influence many processes related to cancer progression and metastasis. In epithelial ovarian cancer these extracellular vesicles (EVs) have been shown to favor different steps of the peritoneal dissemination cascade by changing the functional phenotype of cancer cells and PMCs. Little is currently known, however, about the roles played by exosomes in the pathogenesis and peritoneal metastasis cascade of CRC and especially about the molecules that mediate their interaction and uptake by target PMCs and tumor cells. We isolated exosomes by size-exclusion chromatography from CRC cells and performed cell-adhesion assays to immobilized exosomes in the presence of blocking antibodies against surface proteins and measured the uptake of fluorescently-labelled exosomes. We report here that the interaction between integrin α5β1 on CRC cells (and PMCs) and its ligand ADAM17 on exosomes mediated the binding and uptake of CRC-derived exosomes. Furthermore, this process was negatively regulated by the expression of tetraspanin CD9 on exosomes.

Indexed as

ADAM17 ProteinAdenocarcinomaCell AdhesionCell Line, TumorColorectal NeoplasmsEpitheliumExosomesFibronectinsHumansIntegrin alpha5beta1PeritoneumTetraspanin 29ADAM17 ProteinFibronectinsIntegrin alpha5beta1Tetraspanin 29ADAM17/TACEadhesion moleculescolorectal cancerexosomesextracellular vesiclesintegrin α5β1peritoneal metastasistetraspanin CD9

Identifiers

PMID34576100
PMCPMC8471098
OpenAlexW3201004390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.